Endocrine Abstracts

Introduction: Immune checkpoint inhibitors (ICIs) are a type of immunotherapy approved for the treatment of certain tumors. As the use of ICIs increases, the incidence of rare side effects, called immune-related adverse effects (IRAE), is also increasing, and can affect different systems (gastrointestinal, hepatic, and endocrine among others), with hyponatremia being a possible side effect in patients treated with ICIs. Our objective is to describe one of the few clinical case...